CELEX: 62009TO0024
Language: en
Date: 2010-06-16 00:00:00
Title: Order of the General Court (Fourth Chamber) of 16 June 2010. # Biocaps v European Commission. # Competition - Administrative procedure - Decision ordering an inspection - Article 20(4) of Regulation (EC) No 1/2003 - Existence of the addressee of the decision - Action manifestly unfounded in law. # Case T-24/09.

Order of the General Court (Fourth Chamber) of 16 June 2010 – Biocaps v Commission
      (Case T-24/09)
      Competition – Administrative procedure – Decision ordering an inspection – Article 20(4) of Regulation (EC) No 1/2003 – Existence of the addressee of the decision – Action manifestly unfounded in law
      1.                     Competition – Administrative procedure – Decision ordering an inspection – Addressee (Council Regulation No 1/2003, Art. 20(4))
            (see paras 25-26)
      2.                     Competition – Administrative procedure – Commission’s power of inspection – Decision ordering a legal person and the entities
            controlled by it to submit to an inspection – Scope (Council Regulation No 1/2003, Art. 20(4)) (see para. 32)
      Re:
      
         
               APPLICATION for annulment of Commission Decision C(2008) 6524 of 29 October 2008, in Case COMP/39510, ordering Laboratoire
                  Champagnat Desmoulins Philippakis, and all of the entities controlled directly or indirectly by it, to submit to an inspection
                  pursuant to Article 20(4) of Council Regulation (EC) No 1/2003 of 16 December 2002 on the implementation of the rules on competition
                  laid down in Articles 81 [EC] and 82 [EC] (OJ 2002 L 1, p. 1).
               
            Operative part 
      
         
                  1.
               
               
                  
               
               
                  	The action is dismissed as manifestly unfounded in law.
               
            
         
                  2.
               
               
                  
               
               
                  	Biocaps is ordered to bear its own costs and those incurred by the European Commission.